Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Ketamine in Major Depressive Episode
NCT02992496Phase 2Unknown
- Sponsor
- Medical University of Vienna
- Start
- Apr 2017
- Primary completion
- Dec 2020
- Countries
- 1
01
Overview
A Phase 2 trial of ketamine in major depressive episode (MDE), sponsored by Medical University of Vienna. Status: unknown.
02
Drugs
ketamine
03
Conditions
major depressive episode (MDE)
Beyond the preview
Go deeper on NCT02992496.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02992496.